• Home
  • European Hematology Association Hybrid Congress 2024

EHA 2024


Madrid, Spain

European Hematology Association Hybrid Congress 2024
Explore more Hematology congress materials
Material Type

Results(3)

Hematology-Oncology
A Randomized Comparison of CPX-351 and FLAG-Ida in High-Risk Myelodysplastic Syndrome (MDS): a Subgroup Analysis of UK NCRI AML19
Author(s): Alex Legg, Jazz Pharmaceuticals, Oxford, UK, et al.
Real-World Experience With CPX-351 Treatment for Acute Myeloid Leukemia in England: Updated Analysis of the Cancer Analysis System Database
Author(s): Alexandrina Lambova, IQVIA Inc., London, UK, et al.
Impact of Conditioning Intensity on Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Severity and Outcomes in Adult Hematopoietic Cell Transplant Patients: Results From the DEFIFrance Registry
Author(s): Mohamad Mohty, Hôpital St Antoine, Université Sorbonne, INSERM UMRS 938, Paris, France, et al.